TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from WuXi XDC Cayman, Inc. ( (HK:2268) ).
WuXi XDC Cayman Inc. announced the successful passing of a resolution at their Extraordinary General Meeting held on October 9, 2025. The resolution involved a subscription agreement with WuXi Biologic (Cayman) Inc. for the issuance of 24,134,000 new shares at HK$58.85 per share, which was unanimously approved by the shareholders. This agreement is expected to strengthen WuXi XDC’s capital base and enhance its strategic positioning in the market.
The most recent analyst rating on (HK:2268) stock is a Buy with a HK$90.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
More about WuXi XDC Cayman, Inc.
Average Trading Volume: 6,902,853
Technical Sentiment Signal: Buy
Current Market Cap: HK$103.1B
For an in-depth examination of 2268 stock, go to TipRanks’ Overview page.